See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← DPT page
XStocksXray
Market X-Ray report · 23 October 2026

ST Dupont (DPT)

Euronext Paris · France · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 0.084
52-week range0.072 – 0.093
Return, 1 month / 3 months+2.4% / +7.1%
Return, 1 year / 3 years−6.7% / −14.6%
TrendBelow its 200-day average
RSI (14)43
Volatility (1 year)36.5%
Worst drawdown (1 year)-21.4%
Average daily value traded0.00M EUR
Dividend yield–

Market X-Ray price-based

61/ 100 · High confidence · ahead of 66% of stocks on this exchange
Trend73
Momentum63
Stability (higher is calmer)68
Liquidity25
Income–

Five-year price chart navy: price · brown: 200-day average

0.040.070.090.120.152021-102023-012024-042025-082026-10

About the company

S.T. Dupont is a French luxury goods company based in Paris that makes and sells high-end lighters, writing instruments, leather goods and smoking accessories. Its products are crafted items aimed at affluent customers and collectors, sold through the company's own boutiques and selected specialist retailers in France and abroad. The house has a long heritage in fine metalwork and lacquer finishes, and its range also includes small leather accessories and gifts that carry the same emphasis on craftsmanship and design.

On this site ST Dupont appears as a stock on the Euronext Paris (France), code DPT, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

ST Dupont (DPT) trades on the Euronext Paris in France. It last closed at EUR 0.084 on 23 October 2026.

Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 212 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 6.7% and over the last three months it rose 7.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
ST Dupont (DPT)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend73 · StrongTrading above its long-term averages and near its highs.
Above 200-day average-3.8%
From 52-week high-8.5%
Momentum63 · FairTypical recent returns for this exchange.
3-month return7.1%
6-month return-5.8%
12-month return, skipping the last month-8.9%
Stability (higher is calmer)68 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)36.5%
Worst drawdown, 1 year (smaller is calmer)-21.4%
Liquidity25 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.00M EUR
Zero-volume days1.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−0.5%
1 month+2.4%
3 months+7.1%
6 months−5.8%
1 year−6.7%
3 years−14.6%
5 years−1.2%

Signals

50-day / 200-day average0.087 / 0.087
Golden / death cross (60 days)Golden, 4 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.004

Technical summary

DailyStrongly bearish1 bullish · 3 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026